What does the published scientific research say about Cellulomonas fimi?

Two peer-reviewed PubMed articles index Cellulomonas fimi (formerly also listed as Bacillus fimi) in a plant-input research context, making the published scientific literature a lean but specific body of evidence for this organism.

Both studies concern carbohydrate-binding modules (CBMs) isolated from C. fimi xylanases — specifically CBM2a from xylanase 10A and CBM2b-1-2 from xylanase 11A. Neither paper applies C. fimi itself as a microbial input; instead, researchers expressed isolated CBM proteins transgenically in model plant species to probe cell-wall biology. Growers or formulators searching for what the research says about Cellulomonas fimi and plant growth should note this distinction.

Reported in peer-reviewed research, CBM2a expression in Arabidopsis trended toward increased root and hypocotyl length and enlarged xylem areas, while results in Nicotiana tabacum were subtle or mildly negative for secondary xylem thickness. In Eucalyptus, AtEXP4-driven CBM2a expression was associated with increased plant height and xylem enlargement. The less promiscuous CBM2b-1-2 module produced limited structural changes, confined mainly to vascular tissue in tobacco. These findings address biomass modification potential, not direct field application of C. fimi as a registered or approved biostimulant.